References
- Handa S., Dogra S., Kumar B. Comparative efficacy of cetirizine and fexofenadine in the treatment of chronic idiopathic urticaria. J Dermatol Treat 2004; 15: 55–7
- Breneman D., Bronsky E. A., Bruce S., Kalivas J. T., Klein G. L., Roth H. L. Cetirizine and astemizole therapy for chronic idiopathic urticaria: a double‐blind, placebo‐controlled, comparative trial. J Am Acad Dermatol 1995; 33: 192–8
- Finn A. F Jr., Kaplan A. P., Fretwell R., Qu R., Long J. A double‐blind, placebo‐controlled trial of fexofenadine HCl in the treatment of chronic idiopathic urticaria. J Allergy Clin Immunol 1999; 104: 1071–8
- Nelson H. S., Reynolds R., Mason J. Fexofenadine HCl is safe and effective for treatment of chronic idiopathic urticaria. Ann Allergy Asthma Immunol 2000; 84: 517–22
- Paul E., Berth‐Jones J., Ortonne J. ‐P. Fexofenadine hydrochloride in the treatment of chronic idiopathic urticaria: a placebo‐controlled, parallel‐group, dose‐ranging study. J Dermatol Treat 1998; 9: 143–9
- Casale T. B., Gelfand E., Gilmore T., Harvey P. D., Hindmarch I., Simons F. E. Antihistamine Impairment Roundtable. First do no harm: managing antihistamine impairment in patients with allergic rhinitis. J Allergy Clin Immunol 2003; 111: S835–S842